https://financials.akyla.ai/GILD
Gilead Sciences Inc (GILD) Financial Statements, Valuation & DCF | Akyla
Gilead Sciences Inc (GILD) income statement, balance sheet, cash flow, valuation and DCF — every figure from as-filed SEC (XBRL) filings.
gilead sciences incfinancial statementsgildvaluationdcf
https://news.pda.org/company/10591/Gilead%20Sciences%2C%20Inc.
Company details | Gilead Sciences, Inc.
gilead sciences inccompany details
https://www.argentinaentertainmentchannel.com/article/927982571-car-t-cell-therapy-market-set-to-booming-growth-2026-2033-novartis-ag-gilead-sciences-inc
Car T Cell Therapy Market Set to Booming Growth 2026-2033 | Novartis AG, Gilead Sciences, Inc |...
car t cellgilead sciences incset tonovartis agtherapy
https://tritonix.ai/de/whales-institution/gilead-sciences-inc
Gilead Sciences, Inc. Portfolio Tracker & Holding Analysis | Tritonix.ai
Gilead Sciences, Inc. is a leading American biopharmaceutical company founded in 1987 and headquartered in Foster City, California. While primarily…
gilead sciences incportfoliotrackerholdinganalysis
https://www.edgehound.com/stocks/GILD/
GILD | Gilead Sciences, Inc. - Trade Ideas, Price, News Oct 2026
Learn what's latest with Gilead Sciences, Inc. (GILD) stock, see trends, sentiment and forecast trading ideas to help you with your investing.
gilead sciences inctrade ideasgildpricenews
https://extraetf.com/fr/stock-profile/US3755581036
Action Gilead Sciences Inc. | Cours | Dividende | Actus (885823, US3755581036)
Gilead Sciences Inc. (ISIN: US3755581036, WKN: 885823): ✓ Cours de l'action Gilead Sciences Inc. ✓ Rendement du dividende et dates, ✓ Actus ✓ Plan...
gilead sciences incactioncoursdividendeactus
https://tickzen.app/stocks/gild/overview
GILD Stock Price Today (October 2026) — Gilead Sciences, Inc. Analysis & Key Metrics | Tickzen
Gilead Sciences, Inc. (GILD) stock is at $147.92, down 1.67%. Analyst target: $158.65 (7.3% upside). Stock overview including real-time price analysis, analyst...
gilead sciences incstock pricegildtodayoctober